Obesity Drug Deal: Trump Cuts Prices for Patients

Original Article by Rebecca Robbins, Margot Sanger-Katz & Dani Blum | The New York Times | 13 November 2025

The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.

The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Mpox Cases in SA Rise as Local Transmission Accelerates

Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.

Read more...

NHLS Scrambles as Pathology Services Funding Runs Dry

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Read more...

Momentum Group Posts Record Earnings

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Read more...